More from Dan (NTO Founder~Green Needle)

Many people admire Bill Gates for his intelligence, entrepreneurial spirit and, most recently, his philanthropy. That is all well and good, but we mustn’t forget that he is a relentless capitalist who, throughout his life, dedicated his efforts to only one purpose: making a ridiculous sum of money. Let us also not forget that corporations are, by law, required to do everything possible to maximize their profits and therefore, every single action they take should be viewed as a money-making scheme. Sometimes this means repairing or improving their image through seemingly charitable actions that are designed to allow them, in the long term, to exploit more people without scrutiny or resistance. Putting aside conspiracy theories about Gates being a part of a global population-reduction scheme, it is not too far-fetched to say that there has been a systematic historical tendency to use the less developed continents (especially Africa) for non-consensual research to pioneer money-making techniques disguised as development, and that Bill Gates could be a part of this. After all, Big Pharma is one of the most profitable industries on the planet, and it strongly relies on the enforcement of patent extensions and intellectual rights for which Bill Gates is notorious from his work in Microsoft. Africa has been the place most severely affected by the strict patent rights enforced by transnational corporations with support from the International Monetary Fund – World Bank – World Trade Organization (IMF-WB-WTO) cartel. There is also a huge body of documented evidence that the pharmaceutical industry has, for a long time and repeatedly, used vulnerable populations in the developed and developing world as guinea pigs to study disease and test new drugs (e.g. the Tuskegee Experiment, among many others). This is not limited to Big Pharma but applies to nearly every sector of the industrial capitalist economy which, by definition, is based on the exploitation of an underclass. Having established these premises (I invite you to challenge them), let us analyze the facts: Shortly before leaving Microsoft in June 2006, Bill Gates sold $58 million in shares; on November 2, 2012 he sold 5,500,000 shares for $27.95 a share, generating $153.7 million, and more recently, on April 25, 2013, he sold 12,605,492 shares for $390.4 million. These are but a few examples. According to the Security Exchange Commission, Bill Gates sold 90 million shares of Microsoft Corp. in 2012; he currently holds 591 million shares of this company, which amount to around seven percent of the 8.4 billion total, and he continues to be its largest single stockholder. Simultaneously Mr. Gates has invested in firms that specialize in retail (Walmart), food and beverages (Coca Cola & McDonalds), energy and transportation (British Petroleum and Toyota), and Biotech (Nimbus Discovery and Foundation Medicine). But none of these investments match those he made in the pharmaceutical industry. Indeed, one of his first actions after withdrawing his shares from Microsoft when stepping down was to invest in the British Pharmaceutical giant GlaxoSmithKline (GSK). On September 9, 2002, Gates sold almost half a billion dollars of Microsoft stock. Around the same period, in the second half of 2002, he bought 2.5 million shares of Eli Lilly, manufacturer of Prozac, and made other major investments in Merck and Pfizer. On May 17, 2002 the Bill & Melinda Gates Foundation (B&MGF) purchased shares of nine Big Pharma companies, valued at nearly $205 million. This is when we begin to see a shift of Gates’ personal investments to those of his foundation. This was an important step in convincing the rich to donate their personal fortunes to B&MGF: a sort of leadership by example to fool those who need their conscience stroked, or their image restored or improved. As an investor in Merck & Co., Pfizer Inc., Johnson & Johnson and others, the Gates foundation shares financial interests with the makers of AIDS drugs, diagnostic tools, vaccines and other drugs. It should be recalled that Mr. Gates attained his demi-trillionaire status using a “nasty little monopoly-protecting trade treaty” called TRIPS: the Trade- Related Intellectual Property Rights rules of the WTO. The B&MGF’s endowment comes mainly from Mr. Gates’ personal fortune and Berkshire Hathaway stocks given to the Foundation by Hathaway’s CEO Warren Buffett. More recently, other extremely influential people have poured enormous sums into the B&MGF from their personal fortunes. The B&MGF recently decided to focus its efforts on Malaria #TheTrutherHub #TTH #NewTruthOrder #NTO #CogentIe

94 views · Feb 6th, 2020

More from Dan (NTO Founder~Green Needle)

Many people admire Bill Gates for his intelligence, entrepreneurial spirit and, most recently, his philanthropy. That is all well and good, but we mustn’t forget that he is a relentless capitalist who, throughout his life, dedicated his efforts to only one purpose: making a ridiculous sum of money. Let us also not forget that corporations are, by law, required to do everything possible to maximize their profits and therefore, every single action they take should be viewed as a money-making scheme. Sometimes this means repairing or improving their image through seemingly charitable actions that are designed to allow them, in the long term, to exploit more people without scrutiny or resistance. Putting aside conspiracy theories about Gates being a part of a global population-reduction scheme, it is not too far-fetched to say that there has been a systematic historical tendency to use the less developed continents (especially Africa) for non-consensual research to pioneer money-making techniques disguised as development, and that Bill Gates could be a part of this. After all, Big Pharma is one of the most profitable industries on the planet, and it strongly relies on the enforcement of patent extensions and intellectual rights for which Bill Gates is notorious from his work in Microsoft. Africa has been the place most severely affected by the strict patent rights enforced by transnational corporations with support from the International Monetary Fund – World Bank – World Trade Organization (IMF-WB-WTO) cartel. There is also a huge body of documented evidence that the pharmaceutical industry has, for a long time and repeatedly, used vulnerable populations in the developed and developing world as guinea pigs to study disease and test new drugs (e.g. the Tuskegee Experiment, among many others). This is not limited to Big Pharma but applies to nearly every sector of the industrial capitalist economy which, by definition, is based on the exploitation of an underclass. Having established these premises (I invite you to challenge them), let us analyze the facts: Shortly before leaving Microsoft in June 2006, Bill Gates sold $58 million in shares; on November 2, 2012 he sold 5,500,000 shares for $27.95 a share, generating $153.7 million, and more recently, on April 25, 2013, he sold 12,605,492 shares for $390.4 million. These are but a few examples. According to the Security Exchange Commission, Bill Gates sold 90 million shares of Microsoft Corp. in 2012; he currently holds 591 million shares of this company, which amount to around seven percent of the 8.4 billion total, and he continues to be its largest single stockholder. Simultaneously Mr. Gates has invested in firms that specialize in retail (Walmart), food and beverages (Coca Cola & McDonalds), energy and transportation (British Petroleum and Toyota), and Biotech (Nimbus Discovery and Foundation Medicine). But none of these investments match those he made in the pharmaceutical industry. Indeed, one of his first actions after withdrawing his shares from Microsoft when stepping down was to invest in the British Pharmaceutical giant GlaxoSmithKline (GSK). On September 9, 2002, Gates sold almost half a billion dollars of Microsoft stock. Around the same period, in the second half of 2002, he bought 2.5 million shares of Eli Lilly, manufacturer of Prozac, and made other major investments in Merck and Pfizer. On May 17, 2002 the Bill & Melinda Gates Foundation (B&MGF) purchased shares of nine Big Pharma companies, valued at nearly $205 million. This is when we begin to see a shift of Gates’ personal investments to those of his foundation. This was an important step in convincing the rich to donate their personal fortunes to B&MGF: a sort of leadership by example to fool those who need their conscience stroked, or their image restored or improved. As an investor in Merck & Co., Pfizer Inc., Johnson & Johnson and others, the Gates foundation shares financial interests with the makers of AIDS drugs, diagnostic tools, vaccines and other drugs. It should be recalled that Mr. Gates attained his demi-trillionaire status using a “nasty little monopoly-protecting trade treaty” called TRIPS: the Trade- Related Intellectual Property Rights rules of the WTO. The B&MGF’s endowment comes mainly from Mr. Gates’ personal fortune and Berkshire Hathaway stocks given to the Foundation by Hathaway’s CEO Warren Buffett. More recently, other extremely influential people have poured enormous sums into the B&MGF from their personal fortunes. The B&MGF recently decided to focus its efforts on Malaria #TheTrutherHub #TTH #NewTruthOrder #NTO #CogentIe

94 views · Feb 6th, 2020